Journal
JOURNAL OF ORGANIC CHEMISTRY
Volume 87, Issue 2, Pages 1325-1334Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.joc.1c02638
Keywords
-
Categories
Funding
- Royal Society
- Eli Lilly
- University of Southampton
- EPSRC
Ask authors/readers for more resources
An asymmetric synthetic route to (-)-galanthamine, a pharmacologically active alkaloid used for treating early onset Alzheimer's disease, was successfully established with high levels of stereocontrol using transition-metal-mediated reactions.
An asymmetric synthetic route to (-)-galanthamine (1), a pharmacologically active Amaryllidaceae alkaloid used for the symptomatic treatment of early onset Alzheimer's disease, was successfully established with very high levels of stereocontrol. The key to achieving high chemo-and stereo-selectivity in this approach was the use of transition-metal-mediated reactions, namely, enyne ring-closing metathesis, Heck coupling, and titanium-based asymmetric allylation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available